Delivery Order SPE2DB20D2104-SPE2DB25F2021
- Not listed
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 24, 2025, for the supply of Lidocaine 5% patches in a quantity of 30 units, with a ceiling value of $2,722.08. This firm fixed-price delivery order, which is not set-aside, is scheduled for completion by July 25, 2025, and will be performed at AmerisourceBergen's Conshohocken, Pennsylvania facility. The award represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract with...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for Lidocaine 5% Patch 30s under a firm fixed-price contract with a ceiling value of $3,380.41. This non-set-aside delivery order was awarded on August 1, 2025, with an ultimate completion date of August 4, 2025. The product will be delivered to Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate office. This delivery order represents a child contract action under AmerisourceBergen's...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 30, 2025, for Lidocaine 5% Patch 30s with a ceiling value of $5,556.22. This is a firm fixed-price delivery order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. The delivery order is not subject to any small business set-aside designation and represents a competitively awarded...
- AmerisourceBergen Drug Corp was awarded a delivery order by the Defense Logistics Agency (DLA) on August 7, 2025, for the supply of Lidocaine 5% Patch 30s with a ceiling value of $10,311.22. This firm fixed-price delivery order, which is not set-aside and was competitively awarded, is set to be completed by August 8, 2025, with performance at the contractor's facility in Conshohocken, Pennsylvania. The award represents a continuation of AmerisourceBergen's role as a critical pharmaceutical...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 13, 2025, for the supply of Lidocaine 5% Patch 30s at a ceiling value of $6,861.83. This firm fixed-price delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, a $999.99 billion global pharmaceutical support vehicle running through December 2026. The delivery order is scheduled for completion by August 14, 2025,...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $1,586.05 for Lidocaine 5% Patch 30s, with an ultimate completion date of August 8, 2025. This non-competitive, firm fixed-price delivery order was issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at $999,999,999.00 through December 2026. The place of performance is AmerisourceBergen's corporate office in...
- The Defense Department's Medical Supply Chain awarded AmerisourceBergen Drug Corp a delivery order valued at $11,326.93 for Lidocaine 5% patches (30-count packages) on August 4, 2025, with completion expected by August 5, 2025. This firm fixed-price, non-set-aside contract represents a routine pharmaceutical procurement under a larger indefinite delivery contract vehicle. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, serves as a critical pharmaceutical distributor for federal...
- The Defense Logistics Agency awarded a delivery order valued at $10,088.44 to AmerisourceBergen Drug Corp for the supply of Lidocaine 5% Patch 30s, with an ultimate completion date of August 15, 2025. This is a firm fixed-price delivery order with no set-aside designation, meaning it was awarded through open competition. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Lidocaine 5% Patch 30s under a firm fixed-price contract valued at $2,421.44, with an ultimate completion date of August 8, 2025. This competitively awarded, non-set-aside delivery order represents a continuation of AmerisourceBergen's role as a critical pharmaceutical distributor for federal medical procurement. The work will be performed at the company's corporate office location in...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 18, 2025, for the supply of Lidocaine 5% Patch 30s, with a ceiling value of $8,687.75. This competitively awarded, non-set-aside contract operates under firm fixed pricing with an ultimate completion date of July 21, 2025. The products will be delivered to AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, which serves as the company's headquarters and primary distribution...
- SPE2DB20D2104Indefinite Delivery Contract
- SPE2DB20D2104-SPE2DB25F2021Delivery Order
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 5, 2025, for the supply of Lidocaine 5% Patch 30s, with a ceiling value of $2,551.95 under a firm fixed-price contract type. This non-set-aside award represents a routine pharmaceutical delivery fulfilling federal medical procurement requirements. The place of performance is located in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters. This delivery order is issued under the company's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), a $999,999,999.00 prime vendor agreement valued through December 2026 that serves as a comprehensive global pharmaceutical support vehicle. AmerisourceBergen Drug Corp is a major pharmaceutical distributor providing critical medical supplies to military and veteran healthcare systems, the Defense Health Agency, U.S. Coast Guard, and other federal government healthcare entities. The company has demonstrated capability to compete successfully for open-market federal procurements across a broad spectrum of therapeutic domains, ranging from specialty medications and generic drugs to vaccines and medical devices. The underlying IDC with DLA Troop Support Medical enables AmerisourceBergen to supply pharmaceutical products on a global basis to support military healthcare programs, positioning the company as a key vendor within the Defense Logistics Agency's pharmaceutical supply chain infrastructure.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $2.6k | 8/5/25 |